Ethyl 2,5-dichlorothiazole-4-carboxylate, 95.0%, 5g

4-Chlorobenzenesulfinic acid, 98%, 5g

Ethyl 5-nitro-1H-imidazole-2-carboxylate, 95.0%, 10g

butyl[(4-ethoxyphenyl)methyl]amine, 95.0%, 10g

(S)-3-(4-Acetamidophenyl)-2-((tert-butoxycarbonyl)amino)propanoic acid, 95.0%, 1g

1-(4-Hydroxyphenyl)cyclopropane-1-carbonitrile, 98%, 1g

(2-Chloro-6-methylpyridin-4-yl)boronic acid, 95.0%, 10g

4-Chloro-3-fluoronitrobenzene, 95.0%, 100g

3-Amino-4-iodopyridine, 95.0%, 5g

1,4,5-trimethyl-1H-imidazole-2-carbaldehyde, 95.0%, 250mg

1-(5-Bromo-2-fluorophenyl)-2,2,2-trifluoroethanol, 95%, 100mg

E-Plan phase EPLPH S40x/0.65 objective. Working distance 0.64 mm

2-(Methylamino)isobutyric Acid>98.0%(T)5g